BRCA2 and Miyoshi myopathy: BRCA2 mutation frequency was 12.5% (9 of 72) in our data set and similarly distributed across cancer cohorts (HGSC: 0/19, TNBC: 1/21, HGSC 2/21, MM: 2/12, and Mixed: 4/28).